Protalix is a publicly traded biotechnology company (NYSE Amex: PLX), that is producing recombinant therapeutic proteins through the ProCellEx™ plant cell system.

EVENT CALENDER
Date Event Conference Location
February 10-12, 2010 6th Annual Lysosomal Disease Network: WORLD Symposium Miami, Florida
May 3-6, 2010 Bio Conference 2010 Chicago



© 2007 Protalix Biotherapeutics. All Rights Reserved.